These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33776821)

  • 21. Repeated Clozapine Increases the Level of Serotonin 5-HT
    Szlachta M; Kuśmider M; Pabian P; Solich J; Kolasa M; Żurawek D; Dziedzicka-Wasylewska M; Faron-Górecka A
    Front Mol Neurosci; 2018; 11():40. PubMed ID: 29497362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing sertindole to other new generation antipsychotics on preferential dopamine output in limbic versus striatal projection regions: mechanism of action.
    Hertel P
    Synapse; 2006 Dec; 60(7):543-52. PubMed ID: 16952163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
    Markianos M; Hatzimanolis J; Lykouras L
    Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classics in Chemical Neuroscience: Aripiprazole.
    Casey AB; Canal CE
    ACS Chem Neurosci; 2017 Jun; 8(6):1135-1146. PubMed ID: 28368577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile.
    Shayegan DK; Stahl SM
    CNS Spectr; 2004 Oct; 9(10 Suppl 11):6-14. PubMed ID: 15475871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness.
    Amidfar M; Kim YK; Colic L; Arbabi M; Mobaraki G; Hassanzadeh G; Walter M
    Nord J Psychiatry; 2017 May; 71(4):282-288. PubMed ID: 28125323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of clozapine and haloperidol on dopamine receptor mRNA expression in rat striatum and cortex.
    Damask SP; Bovenkerk KA; de la Pena G; Hoversten KM; Peters DB; Valentine AM; Meador-Woodruff JH
    Brain Res Mol Brain Res; 1996 Sep; 41(1-2):241-9. PubMed ID: 8883957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine responsivities of the pituitary dopamine system in male schizophrenic patients during treatment with clozapine, olanzapine, risperidone, sulpiride, or haloperidol.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):141-6. PubMed ID: 11697576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK; Ninan I
    Fundam Clin Pharmacol; 2000; 14(6):529-39. PubMed ID: 11206702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
    Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
    Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological profile of antipsychotics at monoamine receptors: atypicality beyond 5-HT2A receptor blockade.
    Wood MD; Scott C; Clarke K; Cato KJ; Patel N; Heath J; Worby A; Gordon L; Campbell L; Riley G; Davies CH; Gribble A; Jones DN
    CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):445-52. PubMed ID: 16918396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blonanserin ameliorates social deficit through dopamine-D
    Takeuchi S; Hida H; Uchida M; Naruse R; Yoshimi A; Kitagaki S; Ozaki N; Noda Y
    Neurochem Int; 2019 Sep; 128():127-134. PubMed ID: 30998952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets.
    Baba S; Murai T; Nakako T; Enomoto T; Ono M; Shimizu I; Ikeda K
    Behav Brain Res; 2015; 287():120-6. PubMed ID: 25804359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine D2 and serotonin 5-HT1A receptor interaction in the context of the effects of antipsychotics - in vitro studies.
    Łukasiewicz S; Błasiak E; Szafran-Pilch K; Dziedzicka-Wasylewska M
    J Neurochem; 2016 May; 137(4):549-60. PubMed ID: 26876117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early antipsychotic exposure affects serotonin and dopamine receptor binding density differently in selected brain loci of male and female juvenile rats.
    Lian J; Pan B; Deng C
    Pharmacol Rep; 2016 Oct; 68(5):1028-35. PubMed ID: 27428765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous in-vivo receptor occupancy assays for serotonin 1A, 2A, and dopamine 2 receptors with the use of non-radiolabelled tracers: Proposed method in screening antipsychotics.
    Thentu JB; Nirogi R; Bhyrapuneni G; Ajjala DR; Aleti RR; Palacharla RC
    J Pharmacol Toxicol Methods; 2017; 85():22-28. PubMed ID: 28063918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine D2/3 receptor binding potential and occupancy in midbrain and temporal cortex by haloperidol, olanzapine and clozapine.
    Tuppurainen H; Kuikka JT; Viinamäki H; Husso M; Tiihonen J
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):529-37. PubMed ID: 19496999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
    Futamura T; Ohashi Y; Yano K; Takahashi Y; Haga K; Fukuda T
    Nihon Yakurigaku Zasshi; 1996 May; 107(5):247-53. PubMed ID: 8690306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action.
    López-Gil X; Artigas F; Adell A
    Int J Neuropsychopharmacol; 2009 May; 12(4):487-99. PubMed ID: 18752722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.